Contrast-enhanced ultrasound-guided feeding artery ablation as add-on to percutaneous radiofrequency ablation for hypervascular hepatocellular carcinoma with a modified ablative technique and tumor perfusion evaluation

References

• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. J Vasc Interv Radiol. 2014;25(11):1691–1705.e1694.
   PubMed Web of Science ®Google Scholar
• Kim YS, Rhim H, Cho OK, et al. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol. 2006;59(3):432–441.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vascular Interventional Radiol. 1998;9(1):101–111.
   PubMed Web of Science ®Google Scholar
• Fukuda H, Numata K, Moriya S, et al. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation–propensity score matching analysis. Radiology. 2014;272(2):598–604.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Kamel IR, Kruskal JB, et al. Radiofrequency ablation of hepatic tumors: Increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgenol. 2002;179(1):93–101.
   PubMed Web of Science ®Google Scholar
• Sudheendra D, Neeman Z, Kam A, et al. Intermittent hepatic vein balloon occlusion during radiofrequency ablation in the liver. Cardiovasc Intervent Radiol. 2006;29(6):1088–1092.
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Kimura T, Kurokawa F, et al. Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma. J Gastroenterol. 2005;40(2):171–178.
   PubMed Web of Science ®Google Scholar
• Peng ZW, Zhang YJ, Liang HH, et al. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology. 2012;262(2):689–700.
   PubMed Web of Science ®Google Scholar
• Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013;31(4):426–432.
   PubMed Web of Science ®Google Scholar
• Frich L, Mala T, Gladhaug IP. Hepatic radiofrequency ablation using perfusion electrodes in a pig model: effect of the Pringle manoeuvre. Eur J Surg Oncol. 2006;32(5):527–532.
   PubMed Web of Science ®Google Scholar
• Chen MH, Yang W, Yan K, et al. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach. Abdom Imaging. 2008;33(4):428–436.
   PubMedGoogle Scholar
• Cheng YT, Jeng WJ, Lin CC, et al. Percutaneous radiofrequency ablation of tumor feeding artery before target tumor ablation may reduce local tumor progression in hepatocellular carcinoma. Biomed J. 2016;39(6):400–406.
   PubMed Web of Science ®Google Scholar
• Hou YB, Chen MH, Yan K, et al. Adjuvant percutaneous radiofrequency ablation of feeding artery of hepatocellular carcinoma before treatment. World J Gastroenterol. 2009;15(21):2638–2643.
   PubMed Web of Science ®Google Scholar
• Santambrogio R, Costa M, Barabino M, et al. Laparoscopic radiofrequency of hepatocellular carcinoma using ultrasound-guided selective intrahepatic vascular occlusion. Surg Endosc. 2008;22(9):2051–2055.
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Lee JC, Yang W, et al. Percutaneous ablation of the tumor feeding artery for hypervascular hepatocellular carcinoma before tumor ablation. Int J Hyperthermia. 2018;35(1):133–139.
   PubMed Web of Science ®Google Scholar
• Lu Y, Liu B, Zheng Y, et al. Application of real-time three-dimensional contrast-enhanced ultrasound using SonoVue for the evaluation of focal liver lesions: a prospective single-center study. Am J Transl Res. 2018;10(5):1469–1480.
   PubMed Web of Science ®Google Scholar
• Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–750.
   PubMed Web of Science ®Google Scholar
• Ohta K, Shimohira M, Hashizume T, et al. Identification of the feeding arteries of hepatocellular carcinomas by performing dual arterial phase CT during pre-transarterial chemoembolization angiography. Abdom Radiol. 2019;44(6):2276–2282.
   PubMed Web of Science ®Google Scholar
• Li XJu, Lin MXia, Xie XYan, et al. Different heating modes of Cool-tip on coagulation zone and thermal distribution: in vitro and in vivo experiment. Chin J Ultrasonogr. 2016;25(6):72–77.
   Google Scholar
• Numata K, Tanaka K, Mitsui K, et al. Flow characteristics of hepatic tumors at color Doppler sonography: correlation with arteriographic findings. Am J Roentgenol. 1993;160(3):515–521.
   PubMed Web of Science ®Google Scholar
• Wang X, Erinjeri JP, Jia X, et al. Pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of liver tumors predicts subsequent treatment response. Cardiovasc Intervent Radiol. 2013;36(4):1030–1038.
   PubMed Web of Science ®Google Scholar
• Woo S, Lee JM, Yoon JH, et al. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results. Radiology. 2013;268(2):589–600.
   PubMed Web of Science ®Google Scholar
• Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36(1):166–175.
   PubMed Web of Science ®Google Scholar
• Miyayama S, Yamashiro M, Shibata Y, et al. Variations in feeding arteries of hepatocellular carcinoma located in the left hepatic lobe. Jpn J Radiol. 2012;30(6):471–479.
   PubMed Web of Science ®Google Scholar
• de Korompay N, Alshammari M, Klass D, et al. Intraprocedural parenchymal blood volume is a predictor of treatment response for chemoembolization in hepatocellular carcinoma: results of a prospective study. J Vasc Interv Radiol. 2018;29(7):928–935.
   PubMed Web of Science ®Google Scholar
• Kaufmann S, Schulze M, Spira D, et al. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report. Acta Radiol. 2016;57(1):8–12.
   PubMed Web of Science ®Google Scholar
• Ippolito D, Trattenero C, Talei Franzesi C, et al. Dynamic contrast-enhanced magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid for quantitative assessment of vascular effects on hepatocellular-carcinoma lesions treated by transarterial chemoembolization or radiofrequency ablation. J Comput Assisted Tomogr. 2016;40(5):692–700.
   PubMed Web of Science ®Google Scholar
• Lewandowski RJ, Geschwind JF, Liapi E, et al. Transcatheter intraarterial therapies: rationale and overview. Radiology. 2011;259(3):641–657.
   PubMed Web of Science ®Google Scholar
• Guang C, Kawai N, Sato M, et al. Effect of interval between transcatheter hepatic arterial embolization and radiofrequency ablation on ablated lesion size in a swine model. Jpn J Radiol. 2011;29(9):649–655.
   PubMed Web of Science ®Google Scholar
• Lee IJ, Kim YI, Kim KW, et al. Radiofrequency ablation combined with transcatheter arterial embolisation in rabbit liver: investigation of the ablation zone according to the time interval between the two therapies. Br J Radiol. 2012;85(1019):e987–e994.
   PubMed Web of Science ®Google Scholar
• Chuang CH, Chen CY, Tsai HM. Hepatic infarction and hepatic artery pseudoaneurysm with peritoneal bleeding after radiofrequency ablation for hepatoma. Clin Gastroenterol Hepatol. 2005;3(11):A23.
   PubMed Web of Science ®Google Scholar
• Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surgery. 2004;239(4):450–458.
   PubMed Web of Science ®Google Scholar
• Kim YS, Rhim H, Lim HK, et al. Hepatic infarction after radiofrequency ablation of hepatocellular carcinoma with an internally cooled electrode. J Vasc Interv Radiol. 2007;18(9):1126–1133.
   PubMed Web of Science ®Google Scholar
• Poggi G, Teragni C, Gazzaruso C, et al. Massive hepatic infarction complicating ultrasound-guided percutaneous radiofrequency thermal ablation. Liver Int. 2004;24(6):704–705.
   PubMed Web of Science ®Google Scholar
• Jaskolka JD, Asch MR, Kachura JR, et al. Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol. 2005;16(4):485–491.
   PubMed Web of Science ®Google Scholar
• Mohkam K, Dumont PN, Manichon AF, et al. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm. J Hepatol. 2018;68(6):1172–1180.
   PubMed Web of Science ®Google Scholar
• Francica G, Saviano A, De Sio I, et al. Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients. Digestive Liver Dis. 2013;45(4):336–341.
   Web of Science ®Google Scholar
• Ito T, Tanaka S, Iwai S, et al. Outcomes of laparoscopic hepatic resection versus percutaneous radiofrequency ablation for hepatocellular carcinoma located at the liver surface: a case-control study with propensity score matching. Hepatol Res. 2016;46(6):565–574.
   PubMed Web of Science ®Google Scholar